Skip to content

Multidisciplinary Treatment Combined with Non-Pharmacological Airway Clearance Techniques for Preventing Stroke-Associated Pneumonia: A Quasi-Experimental Study

Effectiveness of Multidisciplinary Treatment Combined with Standardized Non-Pharmacological Airway Clearance Techniques in Preventing Stroke-Associated Pneumonia: A Quasi-Experimental Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500101522
Enrollment
Unknown
Registered
2025-04-25
Start date
2024-03-05
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke-Associated Pneumonia

Interventions

Control group:Control group: Conventional treatment and care regiments were used during the intervention, including ? Ward environment: Maintain appropriate temperature and humidity, the temperature i
Intervention group:The risk level of the patients was assessed by the risk assessment scale for stroke-associated pneumonia (no intervention was performed for non-risk patients). According to the doct

Sponsors

Siping City Central People's Hospital, Siping, Jilin,China
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Meet the clinical diagnostic criteria for cerebral stroke; 2. First occurrence of cerebral stroke; 3. The Stroke-Associated Pneumonia (SAP) risk assessment scale indicates the presence of SAP risk (score <= 29 points); 4. Stable vital signs; 5. The patient and their family voluntarily participate in this study and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Patients with mental disorders; 2. Prophylactic use of antibiotics for more than 3 days; 3. Patients with severe underlying diseases of the heart, brain, kidneys, or lungs, or those with compromised immune systems requiring long-term medication; 4. Patients with unhealed rib fractures, unhealed thoracic vertebral fractures, pathological fractures, or severe osteoporosis; 5. Patients with pneumothorax, lung abscess, pulmonary embolism, or thoracic wall diseases; 6. Patients with abnormal structure or function of the oropharynx; 7. Patients with other pulmonary infections; 8. Patients who underwent tracheal intubation before the onset of Stroke-Associated Pneumonia (SAP); 9. Patients whose condition deteriorates and are no longer suitable for continued participation in the study; 10. Patients who refuse to participate in the study or withdraw voluntarily during the study.

Design outcomes

Primary

MeasureTime frame
SAP incidence;clinical pulmonary infection scores;

Secondary

MeasureTime frame
PaCO2 and PaO2 ;intubation days;curative days;hospital stay;

Countries

China

Contacts

Public ContactYingchun Chen

Siping City Central People's Hospital, Siping, Jilin,China

yingchun_3260@163.com+86 138 4440 3756

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026